-Economic and Political Weekly The Ministry of Health and Family Welfare has made public the National Health Policy 2015 Draft for discussion. The draft is more exhaustive and better organised in its coverage compared to the National Health Policy of 2002. It touches upon contemporary issues of concern, including the rapid emergence of chronic non-communicable diseases. From the latest available evidence, issues crucial to tackling chronic illness in India are discussed. Subrata...

-Business Standard After outsourcing primary health care and diagnostic services to private entities, the state plans universal health insurance scheme for treatment at private hospitals The Rajasthan government has decided to provide health insurance to the 70 million residents in the state. The move comes after the government's decision to outsource primary health centres and specialised diagnostic services to private players on Public-Private Partnership (PPP) mode. The Swasthya Bima Yojana scheme is provided...

-Economic and Political Weekly The draft National Health Policy 2015 is an improvement over its predecessors--the policies of 1984 and 2002. However, it also reveals several gaps, inconsistencies and blind spots which tend to dilute otherwise constructive proposals. The purpose of this article is to open up the draft to further public debate and comment. Forum for Medical Ethics Society (fmesmumbai@gmail.com) is a voluntary, non-profit organisation registered in Mumbai. The society was...

-The Hindu Kola Anna Reddy's determination to provide eyesight to the visually challenged has seen him donning the role of an ophthalmologist surgeon as well. KARIMNAGAR: He is a civil engineer by profession. But his grit and determination to provide eyesight to visually challenged persons saw him donning the role of an ophthalmologist surgeon also. Kola Anna Reddy, a senior member of the Lions Club, joined the movement in 2003 and become the...

-The Times of India This may come as a shocker. Newer and more expensive categories of insulin are being aggressively "pushed" by drug companies, and, hence, increasingly prescribed by physicians for diabetics. The newer, second generation (rapid and long acting) versions are priced around Rs 500, three to four times costlier than the older versions - increasing the cost of treatment. Diabetes is growing alarmingly in India, with over 65 million...